# NCT04165772 (NCT04165772)

> Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT04165772
- Phase: PHASE2
- Status: RECRUITING
- Sponsor: Memorial Sloan Kettering Cancer Center
- Conditions: Rectal Adenocarcinoma; Clinical Stage: Stage II (T3-4, N-); Stage III (Any T, N+); Solid Tumor; Solid Tumor, Adult
- Interventions: TSR-042 or Dostarlimab; capecitabine or 5-FU; Intensity Modulated Radiation Therapy (IMRT)
- Enrollment: 212
- Primary outcome: Pathologic complete response (pCR) or complete clinical response (cCR) at 12 months

## Commentary we found

- YouTube: 1
- Podcasts: 1
- X threads: 1

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=nct04165772